ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 4 • 2018 ACR/ARHP Annual Meeting

    Anti-Jo1 Positive Myositis Patients Display a Characteristic IgG Fc-Glycan Profile Which Is Further Enhanced in Anti-Jo1 Autoantibodies

    Catia Fernandes-Cerqueira1,2, Nuria Renard1,2, Antonella Notarnicola1,2, Edvard Wigren1,2,3, Susanne Graslund1,2,3, Roman Zubarev4, Ingrid E. Lundberg1,2 and Susanna L. Lundström4, 1Department of Medicine, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden, 2Center for Molecular Medicine, Stockholm, Sweden, 3Structural Genomics Consortium, Stockholm, Sweden, 4Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry I, Stockholm, Sweden

    Background/Purpose: IgG Fc-glycans affect IgG function and are altered in autoimmune diseases and autoantibodies. Anti-histidyl tRNA synthetase autoantibodies (anti-Jo1) are frequent in myositis associated with…
  • Abstract Number: 5 • 2018 ACR/ARHP Annual Meeting

    Short Chain Fatty Acid Acetate Induces Regulatory B Cells in Mice and Humans, Which Can Protect Against Arthritis

    Claire I. Daien1,2,3, Julie Mielle1,4, Rachel Audo1,2,5, Lake-Ee Quek1, James Krycer1, Gauthier Rathat6, Gabriela Pinget1, Sumaiya Hoque7, Charles Mackay8, Jian Tan9 and Laurence Macia1, 1Charles Perkins Centre, The University of Sydney, Sydney, Australia, 2IGMM, CNRS UMR5535, Montpellier, Montpellier, France, 3Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, 4IGMM CNRS UMR5535, Montpellier, France, 5Rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, 6Arnaud-de-Villeneuve Hospital, Montpellier, France, 7Charles Perkins Centre, The University of Sydney, Sydney, France, 8Monash University, Melbourne, Australia, 9Charles Perkins Centre, The University of Sydney, Montpellier, Australia

    Background/Purpose: Autoimmunity and more broadly non-communicable diseases develop with the imbalance between anti- and pro-inflammatory immune cell subsets, leading to an uncontrolled and damaging inflammation.…
  • Abstract Number: 6 • 2018 ACR/ARHP Annual Meeting

    Ro52/Trim21 Influences Follicular B Cell Homeostasis and Immunoglobulin Production

    Margarita Ivanchenko1, Susanna Brauner2, Gudny Ella Thorlacius1, Aurélie Ambrosi1 and Marie Wahren-Herlenius1, 1Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 2Neuroimmunology Unit, Department of Clinical Neurosciences, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, Solna, Sweden

    Background/Purpose: Systemic rheumatic diseases are characterized by abnormal B cell activation with autoantibody production and hypergammaglobulinemia. The autoantigen Ro52/SSA, also denoted TRIM21, is a major…
  • Abstract Number: 7 • 2018 ACR/ARHP Annual Meeting

    RNA Sequencing Detection of Gene Dysregulation in B Cells Sorted from Salivary Gland Tissue and from Peripheral Blood Reveals New Pathways Involved in Primary Sjögren’s Syndrome Pathophysiology

    Elodie Rivière1,2, Nicolas Tchitchek1, Gaetane Nocturne1,3, Juliette Pascaud1, Saida Boudaoud1, Alice Thai4, Normand Allaire4, Bernd Jagla5, Michael Mingueneau4 and Xavier Mariette1,3, 1Immunology of viral Infections and Autoimmune Diseases, IDMIT, CEA - Université Paris Sud - INSERM U1184, Le Kremlin Bicêtre & Fontenay aux Roses, France, 2Arthritis Fondation Courtin, Paris, France, 3Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, 4Immunology Research, Biogen, Cambridge, MA, 5Biomarker Discovery Platform UTechS CB, Hub de Bioinformatique et biostatistique C3IB, Institut Pasteur, Paris, France

    Background/Purpose: Primary Sjögren's syndrome (pSS) is a chronic auto-immune disorder characterized by lymphocytic infiltrates and destruction of the salivary glands. Chronic B cell activation, the…
  • Abstract Number: 8 • 2018 ACR/ARHP Annual Meeting

    Repertoire Studies in Rheumatoid Arthritis Reveal B-Cell Distortions and Baseline Shifts in Unmutated IgG

    Yan Wang1, Katy A. Lloyd2, Sunithi Gunasekera3, Camilla Eriksson3, Daniel Ramsköld2, Karin Lundberg4, Per-Johan Jakobsson1, Ulf Göransson3, Vivianne Malmström1 and Caroline Grönwall5, 1Rheumatology Unit, Dept. of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 3Division of Pharmacognosy, Dept. of Medicinal Chemistry, Uppsala University, Uppsala, Sweden, 4Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 5Dep. of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: The immunological hallmark of rheumatoid arthritis (RA) is autoreactivity to citrullinated proteins and rheumatoid factor activity. Hence, the adaptive immune system and B cells…
  • Abstract Number: 9 • 2018 ACR/ARHP Annual Meeting

    Integration of Cytokine Profiles with Distinct B-Cell Functions Reveals a Specific Micro-Environmental Framework in Autoimmune Diseases

    Quentin Simon1, Alexis Grasseau2, Bénédicte Rouvière2, Laetitia Le Pottier2, Divi Cornec3, Maria Orietta Borghi4, Rocio Aguilar Quesada5, Yves Renaudineau2,6, Marta Alarcón-Riquelme7, Jacques-Olivier Pers1 and Sophie Hillion2,6, 1U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France, 2U1227, Lymphocytes B et Autoimmunité, Université de Brest, Inserm, Brest, France, 3Hopital La Cavale Blanche, Brest, France, 4University of Milan, IRCCS Istituto Auxologico Italiano, Milan, Italy, 5Biobanco Del Sistema Sanitario Publico de Andalucía, Sevilla, Spain, 6CHU de Brest, Brest, France, 7Medical Genomics, Center for Genomics and Oncological Research (GENYO), Granada, Spain

    Background/Purpose: The functional duality of B cells is central to balance immune homeostasis by regulating or promoting the immune response. However, the mechanisms by which…
  • Abstract Number: 10 • 2018 ACR/ARHP Annual Meeting

    Fibroblast like Synoviocytes (FLS) Are Capable of Inducing Phenotypical Changes Including Class Switch Recombination (CSR) in Naive B Cells, but Additional Factors Are Required to Trigger Immunoglobulin Secretion

    Dennis Bleck1, Torsten Lowin2, Matthias Schneider3 and Georg Pongratz4, 1Rheumatology Policlinic & Hiller Research Unit, Medical Faculty, University Hospital, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany, 2Department and Hiller Research Center for Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany, 3Department and Hiller Research Center for Rheumatology, Heinrich-Heine University, Duesseldorf, Germany, 4Dpt. of Rheumatology - Hiller Research Center Rheumatology, University Hospital Duesseldorf, Duesseldorf, Germany

    Background/Purpose: Rheumatoid Arthritis (RA) is a disease characterized by chronic inflammation of the synovial tissue in joints. It is driven by highly activated B cells.…
  • Abstract Number: 11 • 2018 ACR/ARHP Annual Meeting

    PAD4-Independent Interaction of ACPA with Nuclear Antigens in Apoptotic Cells and Neutrophil Extracellular Traps (NETs) Defines a Subset of Autoantibodies

    Gustaf Wigerblad1, Katy A. Lloyd1, Peter Sahlström2, Karine Chemin2, Johanna Steen2, Philip J. Titcombe2,3, Diana Zhou2, Ragnhild Stålesen1, Bianka Marklein4, Elena Ossipova2, Johan Rönnelid5, Luca Piccoli6, Antonio Lanzavecchia6, Daniel L. Mueller3, Karl Skriner4, Lars Klareskog2, Fredrik Wermeling1, Vivianne Malmström2 and Caroline Grönwall7, 1Rheumatology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Dept. of Medicine, Karolinska Institutet, Stockholm, Sweden, 3The Center for Immunology, Dept. of Medicine, University of Minnesota Medical School, Minneapolis, MN, 4Dept. of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 5Dept. of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden, 6Università della Svizzera italiana, Institute for Research in Biomedicine, Bellinzona, Switzerland, 7Dep. of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) associated anti-citrullinated protein autoantibodies (ACPA) bind a wide range of citrullinated proteins with high cross-reactivity. Recent findings suggest that certain, but…
  • Abstract Number: 12 • 2018 ACR/ARHP Annual Meeting

    Protein Phosphatase 2A, a Serine/Threonine Phosphatase, Is Essential for Optimal B Cell Function

    Esra Meidan1, Hao Li2, Christina Ioannidis3, Wenliang Pan3, Noe Rodriguez Rodriguez4, Jose Crispin4, Sokratis Apostolidis5, John Manis6, Amir Sharabi7, Maria G. Tsokos3 and George C Tsokos8, 1Division of Immunology, Boston Children's Hospital, Boston, MA, 2Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico, 5Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 6Boston Children's Hospital, Boston, MA, 7Department of Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 8Division of Rheumatology, Department of Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, Boston, MA

    Background/Purpose: Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase ubiquitously expressed in eukaryotic cells. PP2A levels and activity are increased in T cells from patients…
  • Abstract Number: 13 • 2018 ACR/ARHP Annual Meeting

    Shared Genetic Origins Among Anti-Proteinase 3 and Anti-Glomerular Basement Membrane Double-Positive Human Autoantibodies

    Jeffrey R. Ord1, Amy G. Clark1 and Mary H. Foster2, 1Duke University Medical Center, Durham, NC, 2Medicine, Duke University Medical Center, Durham, NC

    Background/Purpose: Patients with ANCA vasculitis and anti-glomerular basement membrane (GBM) nephritis (Goodpasture’s Disease) develop pathogenic autoantibodies (autoAb) that destroy the microvasculature in lungs and kidneys.…
  • Abstract Number: 14 • 2018 ACR/ARHP Annual Meeting

    Individual RA-Derived Monoclonal Anti-Citrullinated Protein Autoantibodies (ACPA) Have Extensive Citrulline Multi-Reactivity Demonstrated By a Large-Scale Protein Array Platform

    Peter Sahlström1, Johanna Steen1, Madeleine Jenning2, Philip J. Titcombe1,3, Ute Nonhoff4,5, Ragnhild Stålesen6, Bianka Marklein2, Daniel L. Mueller3, Zoltan Konthur4, Karin Lundberg7, Anca I. Catrina6, Lars Klareskog1, Vivianne Malmström1, Karl Skriner2 and Caroline Grönwall8, 1Rheumatology Unit, Dept. of Medicine, Karolinska Institutet, Stockholm, Sweden, 2Dept. of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany, 3The Center for Immunology, Dept. of Medicine, University of Minnesota Medical School, Minneapolis, MN, 4Engine GmbH, Hennigsdorf, Germany, 5Max Planck Institute of Colloids and Interfaces, Potsdam, Germany, 6Rheumatology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 7Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 8Dep. of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: The presence of serum IgG anti-citrullinated protein autoantibodies (ACPA) in rheumatoid arthritis (RA), is associated with more aggressive disease progression. Although ACPA have been…
  • Abstract Number: 15 • 2018 ACR/ARHP Annual Meeting

    Abnormal ZAP-70 Expression in B Cells: New Potential Role in Tolerance Breakdown

    Mickaël Martin1, Anne-marie KNAPP1, Dana GHERGUS1, Fabien DELMOTTE2, Laurent Vallat3, Cédric SCHLEISS3, Raoul HERBRECHT4, Anne-sophie KORGANOW1, Frédéric GROS1, Sophie JUNG1, Pauline SOULAS-SPRAUEL1, Eric Meffre2 and Thierry Martin5, 1CNRS UPR 3572 "Immunopathology and Therapeutic Chemistry"/Laboratory of Excellence Medalis, Institute of Molecular and Cellular Biology (IBMC), STRASBOURG, France, 2Department of Immunobiology, Yale University School of Medicine, NEW HAVEN, CT, 3Laboratoire d'hematologie, Hopital Hautepierre, STRASBOURG, France, 4Service d'Hématologie et Oncologie, Hôpitaux universitaires de Strasbourg, STRASBOURG, France, 5CNRS UPR 3572 "Immunopathology and Therapeutic Chemistry"/Laboratory of Excellence Medalis, Institute of Molecular and Cellular Biology (IBMC), STRSBOURG, France

    Background/Purpose: Abnormal expression of the tyrosine kinase ZAP-70 by tumoral B cells in chronic lymphocytic leukemia (CLL) is associated with B cell receptor (BCR) hypersignalling…
  • Abstract Number: 16 • 2018 ACR/ARHP Annual Meeting

    Comprehensive Antibody Profiling Using High Density Peptide Arrays Reveals Novel Citrullinated Protein Targets in Rheumatoid Arthritis Serum Samples

    Ken Lo1, Hanying Li2, Eric Sullivan2 and Jigar Patel2, 1Technology Innovation, Roche Sequencing Solutions - Madison, Madison, WI, 2Roche Sequencing Solutions - Madison, Madison, WI

    Background/Purpose: Autoantibodies against citrullinated proteins are found in 64-89% of rheumatoid arthritis (RA) patients, with a specificity of 88-99%. While citrullinated vimentin, fibrin and histone…
  • Abstract Number: 17 • 2018 ACR/ARHP Annual Meeting

    Kappa-Deleting Recombination Excision Circles (KREC) in B Cells and Serum B Cell Activating Factor (BAFF): Possible Aids in Predicting Juvenile Dermatomyositis Response to Rituximab

    Amer khojah1,2, Victoria Hans3, Wilfredo Marin4, Gabrielle A. Morgan4 and Lauren M. Pachman5,6,7, 1Division of Pediatric Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 2Division of Pediatric Allergy Immunology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 3Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 4Cure JM Program of Excellence in Myositis Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 5Cure JM Program of Excellence in Juvenile Myositis Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 6Pediatric Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 7Rheumatology/Immunology, Ann & Robert H. Lurie Children's Hosptial of Chicago, Chicago, IL

    Background/Purpose: Rituximab is used for the treatment of juvenile dermatomyositis (JDM) with variable success. Some of this variability is presumed to be related to the…
  • Abstract Number: 18 • 2018 ACR/ARHP Annual Meeting

    Cytoplasmic FOXO1 Identifies Novel Disease-Activity Associated B Cell Subsets in SLE

    Molly Hritzo1 and Amit Golding2, 1Microbiology and Molecular Immunology, University of Maryland School of Medicine, Baltimore, MD, 210 South Pine Street, Baltimore VA/VAMHCS AND University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: A key integrator of external stimuli in lymphocytes, Forkhead box protein O1 (FOXO1) is a highly attractive factor to study in SLE because it…
  • « Previous Page
  • 1
  • …
  • 1003
  • 1004
  • 1005
  • 1006
  • 1007
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology